Merck’s $780 Million Acquisition of Exelead | McDermott

McDermott Will & Schulte, a global law firm

COVERAGE

Merck’s $780 Million Acquisition of Exelead

January 15, 2022

Read time: 2 min

Byron S. Kalogerou

Partner

Boston

Michael Willey

Associate

Boston

Abigail M. Kagan

Partner

New York – One Vanderbilt Avenue

Jeffrey M. Holdvogt

Partner

Chicago

Raymond A. Jacobsen , Jr.

Partner

Washington, DC

Timothy (Ty) Carson

Counsel

Washington, DC

David M. Wolff

Partner

Chicago

David J. Levine

Counsel

Washington, DC

Ettore Scandale

Partner

Milan

Michael J. Bruno

Partner

Miami

You may also like